Webinar

The Critical Role of 3D Printing in Hip Treatment: How Skeletal Stem Cells Can Augment the Outcome

Up to 27% of hip revisions are re-revisions due to a suboptimal fixation and suboptimal biomechanical reconstruction of the joint when combining standard components. Hip re-revisions are even three times more likely to fail compared to a primary acetabular revision. Learn all about Materialise aMace, the patient-specific implant designed to break the revision cycle.

Prof. Douglas Dunlop, Consultant Orthopaedic Surgeon at Southampton University Hospital in the United Kingdom, shows you hands-on examples that trigger a custom-made hip implant. Moreover, he will comment on the very first case series report focusing on the application of 3D-printed, patient-specific implants that have been augmented with autologous skeletal stem cells.

What you will learn

  • Why Prof. Dunlop believes additive manufacturing (3D printing) offers a significant opportunity for orthopaedic practice, bone tissue engineering, and regenerative medicine.  
  • The benefits of combining accurate clinical diagnostics with template planning and custom-made implants, including hands-on examples and testimonials.  
  • The very first case series study focusing on 11 patients treated with complex hip replacement surgery involving 3D-printed implants with SSCs seeded on to the implant surface to restore the anatomy and improve the skeletal biology.  
  • How to significantly improve the Oxford Hip Score (OHS) between pre-operative and post-operative scores of 11 patients that underwent hip revision surgery.
  • Case study of a 72-year-old patient with painful loosening of left THR acetabular component following a complex history of revisions for recurrent aseptic loosening who, after surgery, benefits from extensive (grade 3) new bone formation at the bone/implant interface.  

Speaker


Share on:

Share on Facebook
Share on Twitter
Share on LinkedIn
Share with Pocket

You might also like

More inspiration